Delivery Order SPE2DB20D9127-SPE2DB25FPRL4
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the vendor's Park Ridge facility and represents a single purchase under the...
- The Defense Logistics Agency awarded a $10,415.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on September 9, 2025, with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor on this award. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. This delivery order is issued under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the company's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order represents a small purchase of contraceptive medical devices issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award was made without set-aside designation, allowing the woman-owned small business based in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems, effective August 18, 2025, with completion targeted for September 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the awardee's facility in Park Ridge, Illinois. This delivery...
- The Defense Logistics Agency awarded a $2,603.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems on July 29, 2025, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, is the prime contractor on this award. This delivery order...
- The Defense Logistics Agency awarded a $20,830.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $14,008.45 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on August 19, 2025, with an ultimate completion date of September 10, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. No set-aside designation was applied to this award, allowing the company to compete directly in the open federal...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRL4Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the vendor's Park Ridge location and represents a discrete purchase under the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026. The parent IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military healthcare facilities nationwide. Mirena systems, a hormonal contraceptive device, fall within the scope of medical products the company regularly supplies to Department of Defense healthcare sites, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/12/25 |